Wilbe Launches London Biotech Lab to Remove Infrastructure Bottlenecks for Science Startups

For science startups transitioning from academia, securing venture-ready lab space is often a major hurdle. Wilbe, a venture fund and training platform, is addressing this challenge with its new White City lab in London—a flexible, fully equipped facility designed to accelerate biotech innovation.

The Biotech Bottleneck: Why Lab Space Matters

Wilbe has trained over 1,400 scientists and backed 22 companies, yet a recurring issue emerged: founders struggled to find affordable, scalable lab infrastructure. This bottleneck slowed progress, with teams losing momentum during fit-outs or procurement delays. By adding physical lab space to its training and investment ecosystem, Wilbe now offers end-to-end support for scientists.

Wilbe’s Solution: A Turnkey Lab for Science Startups

Located in The WestWorks building, the White City facility supports 10–15 companies and up to 80 people. Key features include:

• Ready-to-use wet labs, offices, and meeting rooms
• No long leases or high upfront costs
• Flexible infrastructure for pre-seed to Series B companies

Founders can begin experiments immediately, avoiding the delays of traditional lab setups. The space is designed by scientists, for scientists, ensuring practicality and efficiency.

Ecosystem Advantages in White City

White City’s proximity to Imperial College London, NHS trusts, and a thriving biotech cluster creates a collaborative environment. Founders gain daily access to talent, partners, and early customers—key drivers for rapid innovation. As Ale Maiano, Wilbe’s CEO, explains: “It’s not about real estate—it’s about giving scientists the infrastructure they need to move faster.”

Future Expansion and Vision

Wilbe plans to expand to hubs like Zurich, Berlin, San Francisco, and Austin, with a second London site focused on robotics. This growth underscores a commitment to removing institutional barriers and fostering global science innovation.

Conclusion: Building a Biotech Ecosystem That Works

Wilbe’s White City lab is more than a facility—it’s a catalyst for biotech startups. By eliminating infrastructure friction, the platform empowers scientists to focus on breakthroughs. For founders seeking to scale, this model offers a blueprint for success.

FAQs

How does Wilbe’s lab support biotech startups?

Wilbe provides ready-to-use lab space, eliminating delays from fit-outs and reducing upfront costs. This allows teams to focus on research and growth.

What makes White City an ideal location for science startups?

White City’s ecosystem includes top universities, NHS partners, and a deep-tech cluster, fostering collaboration and access to resources.

Can startups at any stage join Wilbe’s program?

Yes, the lab supports companies from pre-seed to Series B, offering scalable infrastructure for evolving needs.

What are Wilbe’s future plans?

Wilbe aims to expand to global hubs like Zurich and San Francisco, with a second London site focused on robotics.

How does Wilbe address institutional barriers for scientists?

By providing flexible, affordable lab space and combining it with training and investment, Wilbe removes friction that slows scientific progress.